Frontiers in Oncology (Jun 2022)

Regulation of SUMOylation Targets Associated With Wnt/β-Catenin Pathway

  • Linlin Fan,
  • Xudong Yang,
  • Minying Zheng,
  • Xiaohui Yang,
  • Yidi Ning,
  • Ming Gao,
  • Shiwu Zhang

DOI
https://doi.org/10.3389/fonc.2022.943683
Journal volume & issue
Vol. 12

Abstract

Read online

Wnt/β-catenin signaling is a delicate and complex signal transduction pathway mediated by multiple signaling molecules, which plays a significant role in regulating human physiology and pathology. Abnormally activated Wnt/β-catenin signaling pathway plays a crucial role in promoting malignant tumor occurrence, development, recurrence, and metastasis, particularly in cancer stem cells. Studies have shown that the Wnt/β-catenin signaling pathway controls cell fate and function through the transcriptional and post-translational regulation of omics networks. Therefore, precise regulation of Wnt/β-catenin signaling as a cancer-targeting strategy may contribute to the treatment of some malignancies. SUMOylation is a post-translational modification of proteins that has been found to play a major role in the Wnt/β-catenin signaling pathway. Here, we review the complex regulation of Wnt/β-catenin signaling by SUMOylation and discuss the potential targets of SUMOylation therapy.

Keywords